Immunohematology Market

The global immunohematology market is experiencing steady growth, driven by the increasing demand for blood typing and compatibility testing in blood transfusions and organ transplantation. In 2024, the market was valued at USD 2.0 billion, demonstrating the established need for these critical diagnostic procedures. Projections indicate continued expansion, with the market size estimated to reach USD 2.9 billion by 2033. This growth is characterized by a compound annual growth rate (CAGR) of 4% during the forecast period from 2025 to 2033. North America currently dominates the market, holding a significant market share of over 40.2% in 2024, reflecting the region's advanced healthcare infrastructure and high adoption of immunohematology testing. The immunohematology market encompasses various products and services, including reagents, instruments, and software used for blood grouping, antibody screening, and crossmatching, all playing a crucial role in ensuring patient safety and compatibility in medical procedures.

Grab a sample pdf: https://www.imarcgroup.com/immunohematology-market